BioNTech SE (BNTX) Treasury Shares (2019 - 2025)
BioNTech SE (BNTX) posted Treasury Shares of -$9.0 million for Q4 2025, up 5.35% on a QoQ basis from -$9.5 million in Q3 2025, and up 2.47% year-over-year from -$8.7 million in Q4 2024.
BioNTech SE (BNTX) has 7 years of Treasury Shares data on file, last reported at -$9.0 million in Q4 2025.
- In Q4 2025, Treasury Shares rose 2.47% year-over-year to -$9.0 million; the TTM figure through Dec 2025 stood at -$9.0 million (up 2.47% YoY), while the FY2025 annual figure was -$8.7 million, up 5.34% from the prior year.
- Treasury Shares climbed to -$9.0 million in Q4 2025, from -$9.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at -$4.3 million in Q1 2022 and bottomed at -$11.8 million in Q3 2023.
- A 5-year average of -$8.7 million and a median of -$9.2 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares tumbled 175.96% — and 2025, when it increased 26.48%.
- Year by year, Treasury Shares stood at -$4.3 million in 2021, then dropped by 24.39% to -$5.4 million in 2022, then sank by 114.9% to -$11.6 million in 2023, then climbed by 20.91% to -$9.2 million in 2024, then gained by 2.47% to -$9.0 million in 2025.
- The last three Treasury Shares figures came in at -$9.0 million (Q4 2025), -$9.5 million (Q3 2025), and -$9.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.96 Mn |
| Dec 31, 2025 | -8.96 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Dec 31, 2023 | -11.62 Mn |
| Dec 31, 2023 | -11.62 Mn |
| Sep 30, 2023 | -11.76 Mn |
| Sep 30, 2023 | -11.76 Mn |
| Jun 30, 2023 | -9.58 Mn |
| Jun 30, 2023 | -9.58 Mn |
| Mar 31, 2023 | -8.16 Mn |
| Mar 31, 2023 | -8.16 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Sep 30, 2022 | -10.39 Mn |
| Sep 30, 2022 | -10.39 Mn |
| Jun 30, 2022 | -6.30 Mn |
| Jun 30, 2022 | -6.30 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Dec 31, 2021 | -4.35 Mn |
| Dec 31, 2021 | -4.35 Mn |
| Mar 31, 2021 | -5.79 Mn |
| Mar 31, 2021 | -5.79 Mn |
| Dec 31, 2020 | 5.72 Mn |
| Dec 31, 2020 | 5.72 Mn |
| Dec 31, 2019 | -6.12 Mn |
| Dec 31, 2019 | -6.12 Mn |
| Sep 30, 2019 | -6.15 Mn |
| Sep 30, 2019 | -6.15 Mn |